For patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after 2 prior systemic treatments did not work.
For US Residents Only
For US Residents Only
REZUROCK was evaluated in 2 clinical studies that included a total of 186 people with chronic GVHD. One study, called the ROCKstar study, had 132 people. The other study, called the KD025-208 study, had 54 people.
|
People who saw results in the REZUROCK clinical trials included
|
|
|||
People who saw results in the REZUROCK clinical trials included
|
Some people taking REZUROCK also had
What are the side effects of REZUROCK?
REZUROCK may affect fertility in males and females. Talk with your health care provider if this is a concern for you.
These are not all of the side effects of REZUROCK.
GVHD, graft-versus-host disease.